Repository landing page

We are not able to resolve this OAI Identifier to the repository landing page. If you are the repository manager for this record, please head to the Dashboard and adjust the settings.
oaioai:dash.harvard.edu:1/28702415

Treatment of Patients with the Hypereosinophilic Syndrome with Mepolizumab

Authors
Publication date
30 September 2016
Publisher
'Massachusetts Medical Society'
Doi

    Abstract

    The hypereosinophilic syndrome is a group of diseases characterized by persistent blood eosinophilia, defined as more than 1500 cells per microliter with end-organ involvement and no recognized secondary cause. Although most patients have a response to corticosteroids, side effects are common and can lead to considerable morbidity

    Similar works

    Full text

    thumbnail-image

    Harvard University - DASH

    redirect

    This paper was published in Harvard University - DASH.

    Having an issue?

    Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.